Erratum: Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2 (Oncogene (2011) 30 (3887-3899) DOI: 10.1038/onc.2011.112);Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2

Oncogene

Volumn 30, Issue 36, 2011, Pages 3887-3899

  Li, Y ^a,b   Cai, L ^a   Wang, H ^c   Wu, P ^a   Gu, W ^a   Chen, Y ^d   Hao, H ^a   Tang, K ^a   Yi, P ^a   Liu, M ^a   Miao, S ^a   Ye, D ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF AIZU   (Japan)

Author keywords

formyl peptide receptor 2; macrophage colony stimulating factor; macrophages; monocyte chemoattractant protein 1; tumorigenesis

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLONY STIMULATING FACTOR 1; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOCORTIN 1; LIPOPOLYSACCHARIDE; LIPOXIN A; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AMYLOID A; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MACROPHAGE; MALIGNANT TRANSFORMATION; MONOCYTE; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

EID: 85027948252     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.413     Document Type: Erratum

References (49)

1. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C et al. (2009). Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 1171: 59-76.
2. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. (2008). The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66: 1-9. (Pubitemid 351324128)
3. Balkwill F, Mantovani A. (2001). Inflammation and cancer: back to Virchow? Lancet 357: 539-545. (Pubitemid 32173595)
4. Chiang N, Serhan CN, Dahlen SE, Drazen JM, Hay DW, Rovati GE et al. (2006). The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 58: 463-487. (Pubitemid 44394909)
5. Cocco E, Bellone S, El-Sahwi K, Cargnelutti M, Buza N, Tavassoli FA et al. (2010). Serum amyloid A: a novel biomarker for endometrial cancer. Cancer 116: 843-851.
6. Coimbra M, Kuijpers SA, van Seters SP, Storm G, Schiffelers RM. (2009). Targeted delivery of anti-inflammatory agents to tumors. Curr Pharm Des 15: 1825-1843.
7. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. (2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073-1081.
8. Craig M, Ying C, Loberg RD. (2008). Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo. J Cell Biochem 103: 1-8.
9. De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J et al. (2000). LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192: 1069-1074.
10. Duff MD, Mestre J, Maddali S, Yan ZP, Stapleton P, Daly JM. (2007). Analysis of gene expression in the tumor-associated macrophage. J Surg Res 142: 119-128. (Pubitemid 47268005)
11. Duluc D, Corvaisier M, Blanchard S, Catala L, Descamps P, Gamelin E et al. (2009). Interferon-gamma reverses the immuno-suppressive and protumoral properties and prevents the generation of human tumor-associated macrophages. Int J Cancer 125: 367-373.
12. Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J et al. (2007). Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 110: 4319-4330. (Pubitemid 351377797)
13. El Kebir D, Jozsef L, Filep JG. (2008). Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. J Leukoc Biol 84: 600-606.
14. Emoto M, Danbara H, Yoshikai Y. (1992). Induction of gamma/delta T cells in murine salmonellosis by an avirulent but not by a virulent strain of Salmonella choleraesuis. J Exp Med 176: 363-372.
15. Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S et al. (2005). Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24: 1749-1766. (Pubitemid 40461131)
16. Fiore S, Ryeom SW, Weller PF, Serhan CN. (1992). Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. J Biol Chem 267: 16168-16176.
17. Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T, Miyazaki M et al. (2009). Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer 125: 1276-1284.
18. Gao JL, Murphy PM. (1993). Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J Biol Chem 268: 25395-25401. (Pubitemid 23358142)
19. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C et al. (2009). The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvir-onment. Carcinogenesis 30: 377-386.
20. Janssen-Heininger YM, Macara I, Mossman BT. (1999). Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 20: 942-952. (Pubitemid 129540852)
21. Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T et al. (2009). Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15: 114-123.
22. Kuninaka S, Yano T, Yokoyama H, Fukuyama Y, Terazaki Y, Uehara T et al. (2000). Direct influences of proinflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Cytokine 12: 8-11. (Pubitemid 30042675)
23. Lawrence T. (2007). Inflammation and cancer: a failure of resolution? Trends Pharmacol Sci 28: 162-165. (Pubitemid 46483717)
24. Li Y, Ye D. (2010). Cancer therapy by targeting hypoxia-inducible factor-1. Curr Cancer Drug Targets 10: 782-796.
25. Li YS, Wu P, Zhou XY, Chen JG, Cai L, Wang F et al. (2008). Formyl-peptide receptor like 1: a potent mediator of the Ca2+ release-activated Ca2+ current ICRAC. Arch Biochem Biophys 478: 110-118.
26. Martinez FO, Sica A, Mantovani A, Locati M. (2008). Macrophage activation and polarization. Front Biosci 13: 453-461. (Pubitemid 351599757)
27. McMahon B, Stenson C, McPhillips F, Fanning A, Brady HR, Godson C. (2000). Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J Biol Chem 275: 27566-27575.
28. Miao T, Wu D, Zhang Y, Bo X, Subang MC, Wang P et al (2006). Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J Neurosci 26: 9512-9519. (Pubitemid 44396864)
29. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. (2000). M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164: 6166-6173. (Pubitemid 30408793)
30. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B et al. (2000). Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
31. Panzer U, Steinmetz OM, Turner JE, Meyer-Schwesinger C, von Ruffer C, Meyer TN et al. (2009). Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases. Am J Physiol Renal Physiol 297: F429-F439.
32. Peng J, Yang XO, Chang SH, Yang J, Dong C. (2010). IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation. Cell Res 20: 62-71.
33. Pepinsky RB, Sinclair LK, Browning JL, Mattaliano RJ, Smart JE, Chow EP et al. (1986). Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates. J Biol Chem 261: 4239-4246. (Pubitemid 17198864)
34. Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ et al. (2002a). Endogenous lipid-and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8: 1296-1302. (Pubitemid 35373563)
35. Perretti M, Ingegnoli F, Wheller SK, Blades MC, Solito E, Pitzalis C. (2002b). Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation model. J Immunol 169: 2085-2092. (Pubitemid 34857674)
36. Pollard JW. (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78. (Pubitemid 38082155)
37. Sandri S, Rodriguez D, Gomes E, Monteiro HP, Russo M, Campa A. (2008). Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol 83: 1174-1180. (Pubitemid 351960349)
38. Serhan CN, Hamberg M, Samuelsson B. (1984). Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA 81: 5335-5339. (Pubitemid 14048742)
39. Serhan CN, Yacoubian S, Yang R. (2008). Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 3: 279-312. (Pubitemid 351488283)
40. Sironi M, Martinez FO, D'Ambrosio D, Gattorno M, Polentarutti N, Locati M et al. (2006). Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J Leukoc Biol 80: 342-349. (Pubitemid 44835507)
41. Spite M, Serhan CN. (2010). Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 107: 1170-1184.
42. Su SB, Gong W, Gao JL, Shen W, Murphy PM, Oppenheim JJ et al. (1999). A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 189: 395-402. (Pubitemid 29063260)
43. Teng MW, Andrews DM, McLaughlin N, von Scheidt B, Ngiow SF, Moller A et al. (2010). IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis. Proc Natl Acad Sci USA 107: 8328-8333.
44. Varney ML, Olsen KJ, Mosley RL, Bucana CD, Talmadge JE, Singh RK. (2002). Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. in vivo 16: 471-477. (Pubitemid 35460364)
45. Wang Q, Ni H, Lan L, Wei X, Xiang R, Wang Y. (2010). Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res 20: 701-712.
46. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M et al. (2009). International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61: 119-161.
47. Zhang L, Wu P, Jin SW, Yuan P, Wan JY, Zhou XY et al. (2007). Lipoxin A4 negatively regulates lipopolysaccharide-induced differentiation of RAW264.7 murine macrophages into dendritic-like cells. Chin Med J (Engl) 120: 981-987. (Pubitemid 46902178)
48. Zhang T, Ma Z, Wang R, Wang Y, Wang S, Cheng Z et al. (2010a). Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells. Cancer Immunol Immunother 59: 1097-1108.
49. Zhang Z, Huang L, Zhao W, Rigas B. (2010b). Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 70: 2379-2388.